Evidence map›Paper›PMID 38784026›Full record

ArticleThe Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians2024

A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.

M Gabriela Cabanilla, Michael L Bernauer, Matthew J Briski, Liana M Atallah, Jason Koury, Cecilia M Thompson, Chelsea N Rodriguez, Bernadette Jakeman, Thomas F Byrd

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. β-Lactam Adjunctive Therapy Compared to Vancomycin or Daptomycin Monotherapy in Adult Patients With Methicillin-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  5. Adjunctive β-lactams forTherapeutic advances in infectious disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M Gabriela CabanillaDivision of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID https://orcid.org/0000-0001-5402-0240
Michael L BernauerIndependent Researcher, Albuquerque, NM, USA.
Matthew J BriskiDepartment of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Liana M AtallahDivision of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Jason KouryDepartment of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Cecilia M ThompsonTriCore Reference Laboratories, Albuquerque, NM, USA.
Chelsea N RodriguezDepartment of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Bernadette JakemanDepartment of Pharmacy Practice and Administrative Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA.ORCID https://orcid.org/0000-0002-5849-9110
Thomas F ByrdDivision of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacteremiaceftarolinedual therapymethicillin-resistant Staphylococcus aureussalvage therapy

Identifiers

PMID38784026
PMCPMC11110729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.